Indeed, high IFNG and IFNG-related gene signatures in patients with different primary and metastatic tumors (i.e., melanoma, head and neck squamous cell carcinoma, gastric cancer, lung cancer) were associated with effective ICI treatments (67–70). This evidence concerns the gene IFNG and melanoma.